Condition: Autoimmune Hepatitis
Help Advance Autoimmune Hepatitis (AIH) Research
Explore the MERCURY Study: Now enrolling adults with autoimmune hepatitis (AIH).
You may be eligible to join a clinical study exploring if a study drug may help control liver inflammation and reduce the long-term need for steroids in AIH.
Who Can Join
• Adults between the ages of 18–75
• Diagnosed with autoimmune hepatitis
• Symptoms that have not responded well or intolerant to current treatment options for AIH
Why Consider Participating
• Access to physicians with experience working with AIH
• Reasonable reimbursement for travel-related expenses
• The opportunity for eligible participants to receive the study drug during the optional open-label period
Learn More or See If You Qualify